Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07838129
PHASE4
Evaluation of Corneal Endothelium Health Following Articaine Ophthalmic Solution Administration
Sponsor: Laboratoires Thea
View on ClinicalTrials.gov
Summary
The goal of this clinical trial is to evaluate the corneal endothelium health of eyes treated with articaine ophthalmic solution in adult participants.
Official title: A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Evaluation of the Corneal Endothelium Health of Eyes Treated With Articaine Ophthalmic Solution, or Placebo
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
165
Start Date
2027-01
Completion Date
2027-12
Last Updated
2026-09-24
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Articaine (CYKLX)
Two drops of Articaine administered sequentially to the study eye.
DRUG
Vehicle
Two drops of Vehicle administered sequentially to the study eye.